Russian Federation
The autoimmune liver diseases are among the most severe autoimmune diseases and often become the cause of hepatic cirrhosis. Recently special attention has been paid to autoimmune crossing of the two most frequent autoimmune diseases – autoimmune hepatitis and primary biliary cholangitis. The patient of this group are at high risk of developing hepatic cirrhosis with complications and need combined therapy of autoimmune hepatitis and primary biliary cholangitis, which indicates the need for improvingmethods of early diagnostics and therapy of their crossing.
autoimmune liver diseases, autoimmune hepatitis, primary biliary cholangitis, autoimmune crossing syndrome, variant syndrome, hepatic cirrhosis
1. Miller F.W. The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention // Curr Opin Immunol. – 2023 Feb; 80:102266. Doi:https://doi.org/10.1016/j.coi.2022.102266
2. Abend A.H., He I., Bahroos N., Christianakis S., Crew A.B., Wise L.M., Lipori G.P., He X., Murphy S.N., Herrick C.D., Avasarala J., Weiner M.G., Zelko J.S., Matute-Arcos E., Abajian M., Payne P.R., Lai A.M., Davis H.A., Hoberg A.A., Ortman C.E., Gode A.D., Taylor B.W., Osinski K.I., Di Florio D.N., Rose N.R., Miller F.W., Tsokos G.C., Fairweather D. Estimation of prevalence of autoimmune diseases in the United States using electronic health record data // J Clin Invest. – 2024 Dec 12; 135(4):e178722. Doi:https://doi.org/10.1172/JCI178722
3. Filipovic B., Marjanovic-Haljilji M., Blagojevic D., Dragovic M., Krsmanovic E., Matovic A., Panic N., Kiurski S., Zagorac Z., Milanovic M., Markovic O., Djokovic A., Glisic T., Dragasevic S., Popovic D. A Closer Look into Autoimmune Liver Diseases // Int J Mol Sci. – 2025 Feb 21; 26(5):1863. Doi:https://doi.org/10.3390/ijms26051863
4. Trivedi P.J., Hirschfield G.M. Recent advances in clinical practice: epidemiology of autoimmune liver diseases // Gut. – 2021 Oct; 70(10):1989-2003. Doi:https://doi.org/10.1136/gutjnl-2020-322362
5. Lee D.U., Schuster K., Bahadur A., Schellhammer S., Ponder R., Mitchell-Sparke E., Fan G.H., Lee K.J., Chou H., Lominadze Z. Trends of Costs and Admission Rates Among Patients Admitted With Autoimmune Hepatitis: Analysis of US Hospitals Using the NIS Database // J Clin Exp Hepatol. – 2024 Jan–Feb; 14(1):101279. Doi:https://doi.org/10.1016/j.jceh.2023.08.015
6. Sohal A., Nikzad N., Kowdley K.V. Overlap syndromes in autoimmune liver disease: a review // Transl Gastroenterol Hepatol. – 2025 Apr 15; 10:33. Doi:https://doi.org/10.21037/tgh-24-140
7. Corpechot C., Hornus P., Cals M., Rinder P., Marcille T., Malek A., Ben Belkacem K., Gaouar F., Chabane Y., Corret P.A., Squarzoni P., Soret P.A., Lemoinne S., Chazouillères O., Leburgue A. Epidemiology, comorbidities, treatments and outcomes of autoimmune liver diseases: A French nationwide study // JHEP Rep. – 2025 Aug 11; 7(11):101546. Doi:https://doi.org/10.1016/j.jhepr.2025.101546
8. Bakulin I.G., Burlakova S.A., Skazyvaeva E.V., Skalinskaya M.I. Registr pacientov s autoimmunnymi zabolevaniyami pecheni v Sankt-Peterburge: kliniko-epidemiologicheskie dannye // Vestnik Severo-Zapadnogo gosudarstvennogo medicinskogo universiteta im. I.I. Mechnikova. – 2024; 16(2):61–72. Doi:https://doi.org/10.17816/mechnikov627505
9. Martínez Casas O.Y., Díaz Ramírez G.S., Marín Zuluaga J.I., Santos Ó., Muñoz Maya O., Donado Gómez J.H., Restrepo Gutiérrez J.C. Autoimmune hepatitis – primary biliary cholangitis overlap syndrome. Long-term outcomes of a retrospective cohort in a university hospital // Gastroenterol Hepatol. – 2018 Nov; 41(9):544-552. Doi:https://doi.org/10.1016/j.gastrohep.2018.05.019
10. Schulz L., Sebode M., Weidemann S.A., Lohse A.W. Variant syndromes of primary biliary cholangitis // Best Pract Res Clin Gastroenterol. – 2018 Jun-Aug; 34-35:55-61. Doi:https://doi.org/10.1016/j.bpg.2018.06.003
11. Bolis F., Cazzaniga G., Pagni F., Invernizzi P., Carbone M., Gerussi A. The phenotypic landscape of primary biliary cholangitis and autoimmune hepatitis variants // Gastroenterol Hepatol. – 2025 Feb; 48(2):502225. Doi:https://doi.org/10.1016/j.gastrohep.2024.502225
12. Sebode M., Gerussi A. PBC-AIH variant syndrome: emerging new terminology and a new approach to diagnosis and management // Curr Opin Gastroenterol. – 2026 Mar 1; 42(2):68-74. Doi:https://doi.org/10.1097/MOG.0000000000001149
13. Poupon R., Chazouilleres O., Corpechot C., Chrétien Y. Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis // Hepatology. – 2006 Jul; 44(1):85-90. Doi:https://doi.org/10.1002/hep.21229
14. Czaja A.J. Diagnosis and management of the overlap syndromes of autoimmune hepatitis // Can J Gastroenterol. – 2013 Jul; 27(7):417–23. Doi:https://doi.org/10.1155/2013/198070
15. Mack C.L., Adams D., Assis D.N., Kerkar N., Manns M.P., Mayo M.J., Vierling J.M., Alsawas M., Murad M.H., Czaja A.J. Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases // Hepatology. – 2020 Aug; 72(2):671–722. Doi:https://doi.org/10.1002/hep.31065
16. Kuiper E.M., Zondervan P.E., van Buuren H.R. Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome // Clin Gastroenterol Hepatol. – 2010 Jun; 8(6):530-4. Doi:https://doi.org/10.1016/j.cgh.2010.03.004
17. Gerussi A., Invernizzi P., Carbone M. Challenges in the diagnosis and management of AIH-PBC syndrome // JHEP Rep. – 2024 Sep 23; 7(1):101224. Doi:https://doi.org/10.1016/j.jhepr.2024.101224
18. Boberg K.M., Chapman R.W., Hirschfield G.M., Lohse A.W., Manns M.P., Schrumpf E. International Autoimmune Hepatitis Group. Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue // J Hepatol. – 2011 Feb; 54(2):374–85. Doi:https://doi.org/10.1016/j.jhep.2010.09.002
19. You H., Ma X., Efe C., Wang G., Jeong S.H., Abe K., Duan W., Chen S., Kong Y., Zhang D., Wei L., Wang F.S., Lin H.C., Yang J.M., Tanwandee T., Gani R.A., Payawal D.A., Sharma B.C., Hou J., Yokosuka O., Dokmeci A.K., Crawford D., Kao J.H., Piratvisuth T., Suh D.J., Lesmana L.A., Sollano J., Lau G., Sarin S.K., Omata M., Tanaka A., Jia J. APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis // Hepatol Int. – 2022 Feb; 16(1):1–23. Doi:https://doi.org/10.1007/s12072-021-10276-6
20. Wang G., Tanaka A., Zhao H., Jia J., Ma X., Harada K., Wang F.S., Wei L., Wang Q., Sun Y., Hong Y., Rao H., Efe C., Lau G., Payawal D., Gani R., Lindor K., Jafri W., Omata M., Sarin S.K. The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis // Hepatol Int. – 2021 Apr; 15(2):223–257. Doi:https://doi.org/10.1007/s12072-021-10170-1
21. Zhang W., De D., Mohammed K.A., Munigala S., Chen G., Lai J.P., Bacon B.R. New scoring classification for primary biliary cholangitis-autoimmune hepatitis overlap syndrome // Hepatol Commun. – 2018 Feb 20; 2(3):245–253. Doi:https://doi.org/10.1002/hep4.1148
22. Nguyen H.H., Fritzler M.J., Swain M.G. A Review on Biomarkers for the Evaluation of Autoimmune Cholestatic Liver Diseases and Their Overlap Syndromes // Front Mol Med. – 2022 Jul 8; 2:914505. Doi:https://doi.org/10.3389/fmmed.2022.914505
23. Muratori P., Granito A., Pappas G., Pendino G.M., Quarneti C., Cicola R., Menichella R., Ferri S., Cassani F., Bianchi F.B., Lenzi M., Muratori L. The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome // Am J Gastroenterol. – 2009 Jun; 104(6):1420-5. Doi:https://doi.org/10.1038/ajg.2009.126
24. Paterson A.L., Allison M.E., Brais R., Davies S.E. Any value in a specialist review of liver biopsies? Conclusions of a 4-year review // Histopathology. – 2016 Aug; 69(2):315-21. Doi:https://doi.org/10.1111/his.12940
25. Neuberger J., Patel J., Caldwell H., Davies S., Hebditch V., Hollywood C., Hubscher S., Karkhanis S., Lester W., Roslund N., West R., Wyatt J.I., Heydtmann M. Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology // Gut. – 2020 Aug; 69(8):1382–1403. Doi:https://doi.org/10.1136/gutjnl-2020-321299
26. Wang X., Li Y., Jiang L., Zhou M., Zhang X., Wen H. Performance of 2D-shear wave elastography in autoimmune hepatitis-primary biliary cholangitis overlap syndrome // Abdom Radiol (NY). – 2023 Apr; 48(4):1290–1297. Doi:https://doi.org/10.1007/s00261-023-03840-1
27. Wu H.M., Sheng L., Wang Q., Bao H., Miao Q., Xiao X., Guo C.J., Li H., Ma X., Qiu D.K., Hua J. Performance of transient elastography in assessing liver fibrosis in patients with autoimmune hepatitis- primary biliary cholangitis overlap syndrome // World J Gastroenterol. – 2018 Feb 14; 24(6):737–743. Doi:https://doi.org/10.3748/wjg.v24.i6.737
28. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the management of autoimmune hepatitis // J Hepatol. – 2025 Aug; 83(2):453-501. Doi:https://doi.org/10.1016/j.jhep.2025.03.017
29. Van den Brand F.F., van der Veen K.S., Lissenberg-Witte B.I., de Boer Y.S., van Hoek B., Drenth J.P.H., Verdonk R.C., Vrolijk J.M., van Nieuwkerk C.M.J., Bouma G. Dutch Autoimmune Hepatitis Study Group. Adverse events related to low dose corticosteroids in autoimmune hepatitis // Aliment Pharmacol Ther. – 2019 Nov; 50(10):1120–1126. Doi:https://doi.org/10.1111/apt.15528
30. Ye H.L., Zhang J.W., Chen X.Z., Wu P.B., Chen L., Zhang G. Ursodeoxycholic acid alleviates experimental liver fibrosis involving inhibition of autophagy // Life Sci. – 2020 Feb 1; 242:117175. Doi:https://doi.org/10.1016/j.lfs.2019.117175
31. Zhang H., Li S., Yang J., Zheng Y., Wang J., Lu W., Zhou Y., Yin Q., Zhu R., Guo C. A meta- analysis of ursodeoxycholic acid therapy versus combination therapy with corticosteroids for PBC-AIH- overlap syndrome: evidence from 97 monotherapy and 117 combinations // Prz Gastroenterol. – 2015; 10(3):148–55. Doi:https://doi.org/10.5114/pg.2015.51187
32. Lindor K.D., Bowlus C.L., Boyer J., Levy C., Mayo M. Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases // Hepatology. – 2019 Jan; 69(1):394–419. Doi:https://doi.org/10.1002/hep.30145
33. Hirschfield G.M., Bowlus C.L., Mayo M.J., Kremer A.E., Vierling J.M., Kowdley K.V., Levy C., Villamil A., Ladrón de Guevara Cetina A.L., Janczewska E., Zigmond E., Jeong S.H., Yilmaz Y., Kallis Y., Corpechot C., Buggisch P., Invernizzi P., Londoño Hurtado M.C., Bergheanu S., Yang K., Choi Y.J., Crittenden D.B., McWherter C.A. RESPONSE Study Group. A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis // N Engl J Med. – 2024 Feb 29; 390(9):783–794. Doi:https://doi.org/10.1056/NEJMoa2312100
34. Kowdley K.V., Bowlus C.L., Levy C., Akarca U.S., Alvares-da-Silva M.R., Andreone P., Arrese M., Corpechot C., Francque S.M., Heneghan M.A., Invernizzi P., Jones D., Kruger F.C., Lawitz E., Mayo M.J., Shiffman M.L., Swain M.G., Valera J.M., Vargas V., Vierling J.M., Villamil A., Addy C., Dietrich J., Germain J.M., Mazain S., Rafailovic D., Taddé B., Miller B., Shu J., Zein C.O., Schattenberg J.M. ELATIVE Study Investigators’ Group. ELATIVE Study Investigators’ Group. Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis // N Engl J Med. – 2024 Feb 29; 390(9):795–805. Doi:https://doi.org/10.1056/NEJMoa2306185
35. Pedersen M.R., Mayo M.J. Advances in the evaluation and treatment of autoimmune hepatitis // Curr Opin Gastroenterol. – 2024 May 1; 40(3):126–133. Doi:https://doi.org/10.1097/MOG.0000000000001014
36. Yang F., Wang Q., Wang Z., Miao Q., Xiao X., Tang R., Chen X., Bian Z., Zhang H., Yang Y., Sheng L., Fang J., Qiu D., Krawitt E.L., Gershwin M.E., Ma X. The Natural History and Prognosis of Primary Biliary Cirrhosis with Clinical Features of Autoimmune Hepatitis // Clin Rev Allergy Immunol. – 2016 Feb; 50(1):114–23. Doi:https://doi.org/10.1007/s12016-015-8516-5
37. Stoelinga A.E.C., Biewenga M., Drenth J.P.H., Verhelst X., van der Meer A.J.P., de Boer Y.S., Bouma G., de Vries E.S., Verdonk R.C., van der Berg A.P., Brouwer J.T., Vanwolleghem T., Lammers W., Beuers U., Sarasqueta A.F., Verheij J., Roskams T., Crobach S., Tushuizen M.E., van Hoek B. Dutch Autoimmune Hepatitis Study Group. Diagnostic criteria and long-term outcomes in AIH-PBC variant syndrome under combination therapy // JHEP Rep. – 2024 Jun 14; 6(7):101088. Doi:https://doi.org/10.1016/j.jhepr.2024.101088
38. Bhanji R.A., Mason A.L., Girgis S., Montano-Loza A.J. Liver transplantation for overlap syndromes of autoimmune liver diseases // Liver Int. – 2013 Feb; 33(2):210-9. Doi:https://doi.org/10.1111/liv.12027
39. Lee D.U., Ponder R., Lee K., Menegas S., Fan G.H., Chou H., Jung D., Lee K., Hastie D.J., Urrunaga N.H. The differences in post-liver transplant outcomes of patients with autoimmune hepatitis who present with overlapping autoimmune liver diseases // Hepatol Int. – 2023 Jun; 17(3):720–734. Doi:https://doi.org/10.1007/s12072-022-10468-8
